Exact Sciences Corp logo

Exact Sciences Corp

4
1
NEW
NAS:EXAS (USA)   Ordinary Shares
$ 68.93 -1.53 (-2.17%) 04:00 PM EST
At Loss
P/B:
3.99
Market Cap:
$ 12.74B
Enterprise V:
$ 14.84B
Volume:
1.47M
Avg Vol (2M):
2.13M
Trade In:
Volume:
1.47M
At Loss
Avg Vol (2M):
2.13M

Business Description

Exact Sciences Corp logo
Exact Sciences Corp
NAICS : 621511 SIC : 8731
ISIN : US30063P1057

Share Class Description:

EXAS: Ordinary Shares
Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.
Name Current Vs Industry Vs History
Cash-To-Debt 0.34
Equity-to-Asset 0.48
Debt-to-Equity 0.87
Debt-to-EBITDA 47.21
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.95
Distress
Grey
Safe
Beneish M-Score -2.31
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.35
9-Day RSI 56.29
14-Day RSI 56.85
6-1 Month Momentum % 14.78
12-1 Month Momentum % 15.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.17
Quick Ratio 1.98
Cash Ratio 1.42
Days Inventory 67.45
Days Sales Outstanding 30.35
Days Payable 35.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.4
Shareholder Yield % -0.8

Financials (Next Earnings Date:2024-11-05)

EXAS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EXAS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Exact Sciences Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,612.011
EPS (TTM) ($) -0.956
Beta 1.54
Volatility % 59.21
14-Day RSI 56.85
14-Day ATR ($) 2.206945
20-Day SMA ($) 69.6605
12-1 Month Momentum % 15.34
52-Week Range ($) 40.624 - 79.62
Shares Outstanding (Mil) 184.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Exact Sciences Corp Filings

Filing Date Document Date Form
No Filing Data

Exact Sciences Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Exact Sciences Corp Frequently Asked Questions

What is Exact Sciences Corp(EXAS)'s stock price today?
The current price of EXAS is $68.93. The 52 week high of EXAS is $79.62 and 52 week low is $40.62.
When is next earnings date of Exact Sciences Corp(EXAS)?
The next earnings date of Exact Sciences Corp(EXAS) is 2024-11-05.
Does Exact Sciences Corp(EXAS) pay dividends? If so, how much?
Exact Sciences Corp(EXAS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1